| Literature DB >> 30516593 |
Bo Li1,2, Tihua Zheng1,2, Caifang Yan1,2, Wenjun Wang1,2, Jinjin Zhang1, Luping Zhang1,2, Juan Hu2, Li Zhang1,2, Yuzhu Wan2, Minyan Zhang2, Qingyin Zheng1,2,3.
Abstract
We previously developed Cdh23 mutant mice (erl mice) as a model of hearing loss for otoprotective drug evaluation and showed that the erl mutation leads to hearing loss related to endoplasmic reticulum (ER) stress-induced cochlear hair cell apoptosis. Small molecular chemical chaperones, 4-phenylbutyrate (4PBA), targeting ER stress exert a neuroprotective effect. To evaluate whether 4PBA exerts an otoprotective effect, we intraperitoneally injected erl mice with 4PBA daily from postnatal age day 7 up to 12 weeks. Our results showed that treatment with 4PBA significantly alleviated hearing loss and suppressed hair cell death in erl mice. In addition, ER stress-related proteins were downregulated by 4PBA treatment. Our study showed that 4PBA exerts an otoprotective effect, which provides the potential to repurpose the drug for otoprotection.Entities:
Mesh:
Substances:
Year: 2019 PMID: 30516593 PMCID: PMC6355346 DOI: 10.1097/WNR.0000000000001173
Source DB: PubMed Journal: Neuroreport ISSN: 0959-4965 Impact factor: 1.837